EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019–2023): A Hospital-Based Retrospective Analysis

Claudia Daniela Goleanu Vasiloiu, Corneliu Ovidiu Vrancianu iD, Daria Adelina Goleanu, Monica Marilena Tantu, Ortansa Csutak

Pathogens · 13.09.2025 · 14 (9) · 927

DOI: 10.3390/pathogens14090927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 13.09.2025. Verfasst von Claudia Daniela Goleanu Vasiloiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology-Immunology Department, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Escherichia coli Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UB Research Nexus: Transforming Research through Innovation, Digitalization and Exploration at the University of Bucharest, Ministry of Research, Innovation and Digitalization through the National Recovery and Resilience Plan (PNRR) of Romania, Pillar III, The core program within the National Research Development and Innovation Plan, 2022-2027', carried out with the support of the Ministry of Research, Innovation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance (AMR) is a major public health concern. Urinary tract infections (UTIs) account for up to 85–90% of community-acquired cases. The COVID-19 pandemic disrupted healthcare access and may have influenced resistance patterns. In this context, we retrospectively evaluated the antibiotic resistance dynamics of various bacterial strains isolated between 2019 and 2023 in a hospital unit; Methods: A total of 8217 clinical specimens (urine, wound secretions, sputum, pharyngeal exudate, nasal exudate, tracheal secretions, vaginal and cervical secretions, puncture fluids, purulent secretions, blood, ear secretions, eye secretions) were processed using standard microbiological techniques. Pathogen identification and susceptibility testing were performed with the VITEK 2 Compact system, following CLSI guidelines.

Results

Following the analysis of 8217 clinical samples collected over a five-year period (2019–2023), a total of 2900 microorganisms were isolated and identified. Among these, the most frequently encountered were E. coli strains, with 1204 isolates. Urine cultures represented 71.3% of all processed samples. Out of these 5860 urine cultures, 1530 (26%) were positive. The resistance of E. coli strains to ampicillin (48–55.2%), trimethoprim/sulfamethoxazole (22.9–34%), and ciprofloxacin (21.4–31.5%) remained high throughout the period. ESBL-producing strains peaked at 17.6% in 2020, with multidrug resistance rates ranging from 14% to 22.4%.

Conclusions

E. coli strains displayed persistently high resistance to ampicillin, trimethoprim/sulfamethoxazole, and ciprofloxacin, with peaks in ESBL production and multidrug resistance during the COVID-19 pandemic. These trends underscore the importance of continuous surveillance and antibiotic stewardship, with direct implications for empirical UTI therapy and broader strategies to mitigate the public health impact of antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliAnti-Bacterial AgentsEscherichia coli InfectionsDrug Resistance, BacterialHumansRetrospective StudiesMicrobial Sensitivity TestsCOVID-19Urinary Tract InfectionsFemaleSARS-CoV-2HospitalsMaleDrug Resistance, Multiple, BacterialMiddle Aged

Stichwörter der Autor:innen

Escherichia coliantimicrobial resistanceextended-spectrum beta-lactamasesmultidrug resistanceurinary tract infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Microbiology-Immunology Department, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
  • Department of Laboratory Medicine, "Prof. Dr. Constantin Angelescu" Hospital, Aleea Căuzași 49-51, 030167 Bucharest, Romania.
  • Doctoral School, Carol Davila University of Medicine and Pharmacy, Eroii Sanitari 8, District 5, 050474 Bucharest, Romania.
  • The Research Institute of the University of Bucharest-ICUB, Șoseaua Panduri 90, District 5, 050663 Bucharest, Romania.
  • National Institute of Research and Development for Biological Sciences, 296 Splaiul Independentei, District 6, 060031 Bucharest, Romania.
  • Department of General Medicine, Carol Davila University of Medicine and Pharmacy, Eroii Sanitari 8, District 5, 050474 Bucharest, Romania.

ORCID-Profile: Corneliu Ovidiu Vrancianu

Förderung

  • UB Research Nexus: Transforming Research through Innovation, Digitalization and Exploration at the University of Bucharest
  • Ministry of Research, Innovation and Digitalization through the National Recovery and Resilience Plan (PNRR) of Romania, Pillar III
  • The core program within the National Research Development and Innovation Plan, 2022-2027', carried out with the support of the Ministry of Research, Innovation…
  • UB Research Nexus
  • Ministry of Research, Innovation and Digitalization (MCID)

Zitieren

APA

Goleanu Vasiloiu, C. D., Vrancianu, C. O., Goleanu, D. A., Tantu, M. M., & Csutak, O. (2025). Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019–2023): A Hospital-Based Retrospective Analysis. Pathogens, 14(9), 927. https://doi.org/10.3390/pathogens14090927

Vancouver

Goleanu Vasiloiu CD, Vrancianu CO, Goleanu DA, Tantu MM, Csutak O. Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019–2023): A Hospital-Based Retrospective Analysis. Pathogens. 2025;14(9):927. doi:10.3390/pathogens14090927

BibTeX
@article{GoleanuVasiloiu2025,
  author = {Goleanu Vasiloiu, Claudia Daniela and Vrancianu, Corneliu Ovidiu and Goleanu, Daria Adelina and Tantu, Monica Marilena and Csutak, Ortansa},
  title = {Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019–2023): A Hospital-Based Retrospective Analysis},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {927},
  doi = {10.3390/pathogens14090927}
}
Kostenlos starten →